转移性和局部晚期前列腺癌的寿命损失年
基于SEER数据库2004-2021年数据,纳入转移性(21 488例)和局部晚期(53 506例)前列腺癌患者,采用蒙特卡罗法模拟个体生存,用Kaplan-Meier法量化至75岁的平均寿命损失年(YLL)。转移性和局部晚期患者分别损失5.76年和0.77年(p < 0.001),年轻、黑人和未婚个体YLL更显著。
要点
- 转移性前列腺癌患者平均损失5.76年寿命,局部晚期损失0.77年。
- 年龄45-60岁转移性患者YLL达12.15年,年轻患者损失最显著。
- 黑人和未婚转移性患者YLL分别为6.86年和6.66年,为重点干预人群。
核心结论
- 转移性和局部晚期前列腺癌分别导致5.76和0.77年的寿命损失。
- 年轻、黑人和未婚个体受影响最大,应作为早期检测、治疗强化和心理社会干预的重点目标。
研究设计与样本
- 基于SEER数据库2004-2021年的回顾性队列研究,纳入年龄45-75岁的转移性(cM1)和局部晚期(cT3/4,cN1)前列腺癌患者。
- 转移性患者21 488例,局部晚期患者53 506例;采用蒙特卡罗法模拟个体生存,Kaplan-Meier法量化至75岁的平均YLL。
主要发现
- 转移性前列腺癌患者平均YLL为5.76年,局部晚期为0.77年,与对照组比较p < 0.001。
- 转移性患者中,年龄45-60岁YLL为12.15年,2004-2009年诊断者6.37年,黑人6.86年,未婚者6.66年。
- 局部晚期患者呈现相似模式,但绝对YLL值显著更低。
临床怎么用
- 临床应关注年轻、黑人和未婚前列腺癌患者,因其寿命损失更大,需加强早期检测、治疗强化和心理社会支持。
局限性
- 寿命 expectancy 估计方法未考虑合并症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Prostate cancer (PCa) is the second most common cancer-specific cause of death in the USA. However, the effects of metastatic or locally advanced PCa on individual years of life lost (YLL) have not been addressed. METHODS: Within the Surveillance, Epidemiology, and End Results (SEER) database 2004-2021, metastatic (cM1) and locally advanced (cT3/4, cN1) PCa patients aged 45-75 yr were included. The Monte Carlo method was used to simulate and illustrate individual survival according to the Social Security Administration life tables. Subsequently, the average YLL until the age of 75 yr between patients and simulated controls were quantified using the Kaplan-Meier method. KEY FINDINGS AND LIMITATIONS: Overall, 21 488 and 53 506 patients with metastatic and locally advanced PCa, respectively, were included. Metastatic and locally advanced PCa patients lost, respectively, 5.76 and 0.77 yr of life compared with controls (p < 0.001). YLL due to metastatic PCa were most pronounced in younger patients (age 45-60 yr: 12.15 YLL), those diagnosed in more historic years (2004-2009: 6.37 YLL), and Black (6.86 YLL) and unmarried (6.66 YLL) individuals. Similar observations were made in patients with locally advanced PCa, although absolute YLL values were substantially lower. Limitations include the life expectancy estimation method that did not take comorbidities into account. CONCLUSIONS AND CLINICAL IMPLICATIONS: Metastatic and locally advanced PCa resulted in 5.76 and 0.77 YLL values, respectively, relative to controls. Young, Black, and unmarried individuals were affected most. Therefore, these groups represent targets of particular interest for the early detection, treatment intensification, and psychosocial interventions.
引用
- Falkenbach F, Le QC, Longoni M, et al. Years of Life Lost in Metastatic and Locally Advanced Prostate Cancer. Eur Urol Oncol. 2025. PMID: 40675872. doi:10.1016/j.euo.2025.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。